PxPixel
Contribute
CONNECT:
Contribute

research

President Trump Is Leading An Unprecedented Effort To Keep America Safe

POTUS - July 22, 2020

Vaccine Developers Who Have Partnered With The Trump Administration Have Generated Optimism In The Development Of A Potential Vaccine For The Coronavirus

The Facts:

THE TRUMP ADMINISTRATION'S PARTNERSHIP WITH VACCINE DEVELOPERS HAVE PROVIDED POSITIVE RESULTS FOR A POTENTIAL VACCINE

THE TRUMP ADMINISTRATION CONTINUES TO IMPLEMENT POLICIES TO HELP AMERICANS FIGHT THE VIRUS WHILE A VACCINE IS IN DEVELOPMENT

THE TRUMP ADMINISTRATION'S PARTNERSHIP WITH VACCINE DEVELOPERS HAVE PROVIDED POSITIVE RESULTS FOR A POTENTIAL VACCINE

The Trump Administration's Operation Warp Speed Has Been Investing In Vaccine Development To Ensure Americans Receive A Vaccine By Early 2021

The Trump Administration's Operation Warp Speed Has A Goal To Deliver 300 Million Doses Of An Effective Vaccine For COVID-19 By January 2021. " Operation Warp Speed (OWS) aims to deliver 300 million doses of a safe, effective vaccine for COVID-19 by January 2021, as part of a broader strategy to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics (collectively known as countermeasures)." ( HHS , 6/16/20)

The Program Is Making Investments In Vaccine Development To Ensure A Successful Product And Quick Distribution. "The federal government is making investments in the necessary manufacturing capacity at its own risk, giving firms confidence that they can invest aggressively in development and allowing faster distribution of an eventual vaccine. Manufacturing capacity for selected candidates will be advanced while they are still in development, rather than scaled up after approval or authorization. Manufacturing capacity developed will be used for whatever vaccine is eventually successful, if possible given the nature of the successful product, regardless of which firms have developed the capacity." ( HHS , 6/16/20)

On Wednesday, The Trump Administration Announced A Nearly $2 Billion Contract With Pfizer And A Smaller German Biotechnology Company For Up To 600 Million Doses Of A Coronavirus Vaccine. "The Trump administration on Wednesday announced a nearly $2 billion contract with the pharmaceutical giant Pfizer and a smaller German biotechnology company for up to 600 million doses of a Covid-19 vaccine, with the companies on track to manufacture the first 100 million doses by December." ( The New York Times , 7/22/20)

  • The Deal Would Allow The Federal Government To Obtain The First 100 Million Doses For $1.95 Billion, "With Rights To Acquire Up To 500 Million More," And "Americans Would Receive The Vaccine For Free." "Under the arrangement, the federal government would obtain the first 100 million doses for $1.95 billion, with the rights to acquire up to 500 million more. Americans would receive the vaccine for free." ( The New York Times , 7/22/20)

The Trump Administration Has Provided $1.2 Billion In Support For AstraZeneca And The University Of Oxford's Candidate Vaccine, An Agreement Was Made In May To Make Available At Least 300 Million Doses For Americans. "May 21: HHS announced up to $1.2 billion in support for AstraZeneca's candidate vaccine, developed in conjunction with the University of Oxford. The agreement is to make available at least 300 million doses of the vaccine for the United States, with the first doses delivered as early as October 2020 and Phase 3 clinical studies beginning this summer with approximately 30,000 volunteers in the United States." ( HHS , 6/16/20)

The Trump Administration Has Provided $483 Million In Support For Moderna's Candidate Vaccine, Which Began Phase 1 Trials On March 16 And Received A Fast-Track Designation From FDA . "April 16: HHS made up to $483 million in support available for Moderna's candidate vaccine, which began Phase 1 trials on March 16 and received a fast-track designation from FDA." ( HHS , 6/16/20)

  • Moderna Has Been Working Closely With The Trump Administration, And Remains On Track To Be Able To Deliver About "500 Million Doses Per Year, And Possibly 1 Billion Doses Per Year, Beginning In 2021." "Moderna is working closely with Operation Warp Speed (OWS) and the NIH, including NIAID's COVID-19 Prevention Trials Network (COVPN), to conduct the Phase 3 COVE study. Working together with collaborators like NIH, the Company hopes to achieve a shared goal that the participants in the COVE study are representative of the communities at highest risk for COVID-19 and of our diverse society. Moderna has completed manufacture of vaccine required to start the Phase 3 study. With the Phase 3 dose being finalized at 100 μg, the Company remains on track to be able to deliver approximately 500 million doses per year, and possibly up to 1 billion doses per year, beginning in 2021 from the Company's internal U.S. manufacturing site and strategic collaboration with Lonza." (Moderna, Press Release , 7/14/20)

On March 30, 2020, The Trump Administration Announced $456 Million In Support For Johnson & Johnson's Candidate Vaccine, With Phase 1 Clinical Trials Set To Begin This Summer. "March 30: HHS announced $456 million in funds for Johnson & Johnson's candidate vaccine, with Phase 1 clinical trials set to begin this summer." ( HHS , 6/16/20)

On June 1, 2020, HHS Announced A Task Order With Emergent BioSolutions, Which Will Advance Manufacturing Capabilities For A Potential Coronavirus Vaccines, And Therapeutics, Worth Approximately $628 Million. "June 1: HHS announced a task order with Emergent BioSolutions to advance domestic manufacturing capabilities and capacity for a potential COVID-19 vaccine as well as therapeutics, worth approximately $628 million." ( HHS , 6/16/20)

On Monday, Oxford University And AstraZeneca Announced Positive Results From A Large, Early Stage Human Trial For The Coronavirus

On Monday, A Potential Coronavirus Vaccine Developed By Oxford University And AstraZeneca "Produced A Promising Immune Response In A Large, Early-Stage Human Trial." "A potential coronavirus vaccine developed by Oxford University in the U.K. with pharmaceutical giant AstraZeneca has produced a promising immune response in a large, early-stage human trial, according to newly released data published Monday in the medical journal The Lancet. The researchers are calling their experimental vaccine ChAdOx1 nCoV-19. It combines genetic material from the coronavirus with a modified adenovirus that is known to cause infections in chimpanzees. The phase one trial had more than 1,000 participants in people aged 18 to 55." ( CNBC ,7/20/20)

  • The Latest Results Show That Researchers Are On Schedule To Have A Vaccine Ready For Mass Production As Soon As September. "The early but promising Phase 1-2 results mean researchers remain on their schedule to have the shot-described by the World Health Organization's chief scientist last month as the world's most-advanced vaccine candidate-ready for mass production as soon as September." ( The Wall Street Journal , 7/20/20)

Last Week, Moderna Also Provided Positive Results From Their Coronavirus Vaccine Trials And Announced They Will Start Their Final Phase Starting July 27th

Last Week, Moderna, A Massachusetts- Based Biotech Company, Announced They Are Aiming To Begin Its Final Phase Of Testing For A Coronavirus Vaccine July 27. "Moderna is aiming to begin its final phase of testing for its coronavirus vaccine July 27. The Cambridge, Massachusetts-based biotech company is the first in the U.S. to announce an estimated start date for phase 3 trials." ( NBC News , 7/14/20)

Moderna's COVID-19 Vaccine "Led Patients To Produce Antibodies That Can Neutralize The Novel Coronavirus That Causes The Disease." "Moderna's Covid-19 vaccine led patients to produce antibodies that can neutralize the novel coronavirus that causes the disease, though it caused minor side effects in many patients, according to the first published data from an early-stage trial of the experimental shot." ( Stat News , 7/14/20)

Health Experts Have Been Encouraged By The Results, Stating That The Data Looks "Quite Good"

Francis Collins, Director Of The National Institutes Of Health, "That Amongst The Several Vaccine Platforms That Are Being Tested, There Seem To Be Encouraging Phase 1 Data To Suggest That At Least One Of Them Is Going To Work." "'I am cautiously optimistic, based on the data that we've seen so far, that amongst the several different vaccine platforms that are being tested, there seem to be encouraging Phase 1 data to suggest that at least one of them is going to work,' said Francis Collins, director of the National Institutes of Health." ( Stat News , 7/14/20)

Anthony Fauci, Director Of The National Institute For Allergy And Infectious Diseases, "The Data Really Look Quite Good" When Speaking Of The Results From The Moderna Vaccine Development. "'The hallmark of a vaccine is one that can actually mimic natural infection and induce the kind of response that you would get with natural infection. And it looks like, at least in this limited, small number of individuals, that is exactly what's happening,' said Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases, the NIH branch that conducted the trial. 'The data really look quite good," he added. 'There were no serious adverse events.'" ( Stat News , 7/14/20)

The Trump Administration Has Provided Funding To Increase Capacity For Vials And Has Put In Place Preparation Measures To Prepare For The Distribution Of A Vaccine

Two Vaccine Candidates Have Entered Their Final Stage Of Clinical Trials In Record Time, And The White House Has Already Prepared To Start Mass Production Once The Vaccine Becomes Available. PRESIDENT TRUMP: "Two vaccine candidates are entering the final stage of clinical trials this month. This was achieved in record time. It used to be years before you were in a position like we are right now. Four other vaccines will enter final trials in the following weeks, and we're mass producing all of the top candidates so that the first approved vaccine will be available immediately." ( White House , 7/21/20)

  • The Trump Administration Has Announced That The Military Is Prepared To Distribute The Vaccine After it's Development. PRESIDENT TRUMP: "And logistically, we have the military ready to go. We have great people - logistic, military people. A wonderful general who's waiting for the vaccine so they can distribute it in record time. That's what's going to happen. So our military is all set to go. We will deliver a vaccine, therapeutics, whatever it is that's necessary, and defeat the virus once and for all." ( White House , 7/21/20)

On June 9, 2020, "HHS And DOD Announced A Joint Effort To Increase Capacity For Vials That Maybe Needed For Vaccines And Treatments." "June 9: HHS and DoD announced a joint effort to increase domestic manufacturing capacity for vials that may be needed for vaccines and treatments." ( HHS , 6/16/20)

  • The Trump Administration Announced $204 Million To Corning To Expand Domestic Manufacturing Capacity To Produce Additional 164 Million Valor Glass Vials "Each Year If Needed." "$204 million to Corning to expand the domestic manufacturing capacity to produce an additional 164 million Valor Glass vials each year if needed." ( HHS , 6/16/20)
  • Another $143 Million Will Be Going To Si02 Materials Science, In An Effort To Ramp Up Capacity To Produce Glass Coated Plastic Containers, Which Can Be Used For Drugs And Vaccines. "$143 million to SiO2 Materials Science to ramp up capacity to produce the company's glass-coated plastic container, which can be used for drugs and vaccines." ( HHS , 6/16/20)

THE TRUMP ADMINISTRATION CONTINUES TO IMPLEMENT POLICIES TO HELP AMERICANS FIGHT THE VIRUS WHILE A VACCINE IS IN DEVELOPMENT

The Trump Administration Continues To Provide Funding And Necessary Supplies To Local Communities Across The Nation

The Trump Administration Has Coordinated Closely With Hospitals And Governors And Has Provided Recommendations To Assist With Coronavirus Efforts. PRESIDENT TRUMP: "We're coordinating closely with hospitals and governors. In the last three weeks, I've sent senior officials into nine states to meet with governors and provide recommendations to the various leaders of the state, including hospital administrators, et cetera." ( White House , 7/21/20)

As Of July 17th, Under Trump The Administration, FEMA And HHS Has Obligated "$135.9 Billion In Support Of COVID-19 Efforts." "As of July 17th, FEMA and HHS have obligated $135.9 billion in support of COVID-19 efforts. ( DHS , 7/20/20)

As Of July 15th, FEMA And HHS Have Delivered "103.1 Million N95 Respirators, 159.3 Million Surgical Masks, 17.2 Million Face Shields, 139.4 Million Gloves, 68.4 Million Surgical Gowns And 6.1 Million Coveralls." " As of July 15th, FEMA and HHS have coordinated the delivery of 103.1 million N95 respirators, 159.3 million surgical masks, 17.2 million face shields, 139.4 million gloves, 68.4 million surgical gowns and 6.1 million coveralls." ( DHS , 7/20/20)

In Support Of The Trump Administration's Testing Effort, FEMA Has Procured And Delivered More Than 41 Million Swabs And 32.1 Million Units Of Media To States, Territories, And Tribes Across The Country. "FEMA continues to source and procure testing material - specifically, testing swabs and transport media - to support the White House Coronavirus Task Force and the Administration's Testing Blueprint. As of July 19th, FEMA has procured and delivered more than 41 million swabs and 32.1 million units of media. The FEMA-sourced material will be provided to states, territories, and tribes for a limited duration to help increase testing capacity in support of their individualized plans." ( DHS , 7/20/20)

On June 2, 2020, HHS Announced Additional $250 Million In Funding To Continue To Help U.S. Health Care Systems Respond To The Coronavirus. "The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR) is providing an additional $250 million to aid U.S. health care systems treating patients and responding to the COVID-19 pandemic." ( HHS , 6/2/20)

  • The Trump Administration Has Now Authorized A Total Of $350 Million To Health Care Systems For Pandemic Response, "Including $100 Million Released In April 2020." "As authorized by the Coronavirus Aid, Relief, and Economic Security (CARES) Act, HHS has now provided a total of $350 million to health care systems for pandemic response, including $100 million released in April 2020." ( HHS , 6/2/20)

The Trump Administration Has Deployed Over 4,500 Public Health Officers To Assist With The Coronavirus Pandemic. "More than 4,500 of the 6,100 Public Health Service officers have deployed during the COVID-19 pandemic in support of our worldwide efforts, including deploying to the Diamond Princess cruise ship in Japan and repatriating Americans to our military bases. ( HHS , 6/30/20)

  • The Commissioned Corps Officers Have "Assisted Community- Based Testing Sites With Testing And Providing Infection Control And Clinical Care To Long-Term Facilities, Hospitals, And Field Hospitals" In Communities That Have Been Hit Hard By The Virus. "Commissioned Corps officers have assisted community-based testing sites with testing and providing infection control and clinical care to long-term care facilities, hospitals, and field hospitals in hard-hit communities across 28 states, four territories, and numerous Tribes." ( HHS , 6/30/20)

To Ensure The United States Nursing Homes Are Protected And Prepared, The Trump Administration Has Continued To Increase Support

In An Effort To Protect America's Nursing Homes, The Trump Administration Has Shipped 29,191 Packages Of Medical Supplies To "Nursing Homes In 53 States And Territories." "Protecting our Nation's Nursing Homes. As of July 18th, FEMA has shipped 29,191 packages of medical supplies to nursing homes in 53 states and territories." ( DHS , 7/20/20)

FEMA Has Coordinated Two Shipments Totaling A "14- Day Supply Of Personal Protective Equipment TO All 15,400 Medicaid And Medicare Certified Nursing Homes." "FEMA coordinated two shipments totaling a 14-day supply of personal protective equipment to all 15,400 Medicaid and Medicare-certified nursing homes. The shipments will supplement existing efforts to provide equipment to nursing homes." ( DHS , 7/20/20)

In An Effort To Review The Coronavirus Impact, CMS And The White House Has Announced A New Commission, The Independent Coronavirus Commission On Safety And Quality In Nursing Homes "Today, Centers for Medicare & Medicaid Services (CMS) announced that the MITRE Corporation has published the membership of the independent Coronavirus Commission on Safety and Quality in Nursing Homes. CMS, under the leadership of President Trump and his Plan to Open Up America Again, seeks an independent review and comprehensive assessment of the nursing home response to the Coronavirus Disease 2019 (COVID-19) pandemic. The agency tasked the contractor, MITRE, to solicit membership applications, select the members, and facilitate the Commission's work." ( CMS , 6/19/20)

  • The Commission's Review "Will Help Inform Current And Future Response To Coronavirus Or Future Infectious Diseases." "The Commission's review will help inform current and future responses to COVID-19 and potential future infectious disease outbreaks within nursing homes. The Commission will conduct a comprehensive assessment of the overall response to the COVID-19 pandemic in nursing homes. Based on its assessment, the Commission will make recommendations on actions and best practices for immediate and future actions." ( CMS , 6/19/20)

President Trump Has Taken The Lead In Widespread Testing Which Has Saved Lives

Since The Coronavirus Was Declared A National Emergency, Coronavirus Testing Has Increased "Significantly," And Now More Than "600,000 Tests Are Administered Each Day In The United States, Up From About 100,000 Per Day In Early Spring." "Since mid-March, when the coronavirus was declared a national emergency, diagnostic testing for the coronavirus has risen significantly. More than 600,000 tests are administered each day in the United States, up from about 100,000 per day in early spring." ( The New York Times , 7/3/20)

The Increase In Testing "Has Identified Many More Infected Individuals With Mild Or No Symptoms, Driving Down The Overall Proportion Of Patients Who Die From COVID-19." "Although the nation is still falling short of the millions of daily tests that experts have called for, the increased testing has identified many more infected individuals with mild or no symptoms, driving down the overall proportion of patients who die from Covid-19, said Caitlin Rivers, a senior scholar at the Johns Hopkins Center for Health Security." ( The New York Times , 7/3/20)

With Widespread Testing, Infections Have Been "Identified Earlier," Which Has Allowed Health Providers To "Intervene Earlier." "And with more tests available, infections are often identified earlier, 'which allows us to intervene earlier,' said Saskia Popescu, a hospital epidemiologist and infectious disease expert in Arizona." ( The New York Times , 7/3/20)

Per Capita, The U.S. Is Conducting 50% More Tests Than Europe And Is Close To Conducting Over 50 Million Tests In The United States. PRESIDENT DONALD TRUMP: "Per capita, the U.S. is conducting 50 percent more tests than Europe, and we've conducted nearly three times as many tests as all of the other countries in the Western Hemisphere combined. We'll be over 50 million tests. This allows us to isolate those who are infected, even those without symptoms. So we know exactly where it's going and when it's going to be there." ( White House , 7/21/20)

The Trump Administration Has Extended Coronavirus Testing Public-Private Partnership, To "Provide Americans Convenient Access To COVID-19 Testing." "The U.S. Department of Health and Human Services (HHS) will extend its partnership with national pharmacy and grocery retail chains CVS, Rite-Aid, Walgreens, Quest (through services at Walmart) and eTrueNorth (through services at Kroger, Health Mart, and Walmart) so they may continue to seamlessly provide Americans convenient access to COVID-19 testing." ( HHS , 6/30/20)

  • The Partnership Has "Scaled Up To More Than 600 COVID-19 Testing Sites," And "Approximately 70% Of These Testing Sites Are Located In Communities With Moderate-To-High Social Vulnerability." "The partnership, which is part of the Community-Based Testing Program, has scaled up to more than 600 COVID-19 testing sites in 48 states and the District of Columbia. Approximately 70% of these testing sites are located in communities with moderate-to-high social vulnerability, as evidenced by their racial, and ethnic composition, and their housing, economic, language barrier, and similar considerations." ( HHS , 6/30/20)
  • HHS Has Partnered With Morehouse School Of Medicine To Fight Coronavirus "In Racial And Ethnic Minority, Rural And Socially Vulnerable Communities." "The U.S. Department of Health and Human Services (HHS) Office of Minority Health (OMH) announced the selection of the Morehouse School of Medicine as the awardee for a new $40 million initiative to fight COVID-19 in racial and ethnic minority, rural and socially vulnerable communities. The Morehouse School of Medicine will enter into a cooperative agreement with OMH to lead the initiative to coordinate a strategic network of national, state, territorial, tribal and local organizations to deliver COVID-19-related information to communities hardest hit by the pandemic." ( HHS , 6/23/20)
White House POTUS Read more research

Previous post

Vote By Mail Push Leads To Delays, Disaster And Dysfunction

Next post

Americans Are Loving The Trump Tax Cuts
Read more research
JOIN THE TEAM
Sign up today

Most Recent

Trending Topics

Republican National Committee

Connect With Us

Republican National Committee
Chairwoman Ronna McDaniel
Co-Chair Tommy Hicks Jr.
Our GOP
GOP Groups
Action Center
Issues
News & Videos
  • 310 First Street SE, Washington, DC 20003
  • 202-863-8500

By providing your phone number, you are consenting to receive calls and recurring SMS/MMS messages, including autodialed and automated calls and texts, to that number from the Republican National Committee. Msg&data rates may apply. Reply HELP for help, STOP to end. Terms & conditions/privacy policy apply 80810-info.com.

Paid for by the Republican National Committee. Not Authorized By Any Candidate Or Candidate's Committee. www.gop.com

Republican National Committee
Chairwoman Ronna McDaniel
Co-Chair Tommy Hicks Jr.

By providing your phone number, you are consenting to receive calls and recurring SMS/MMS messages, including autodialed and automated calls and texts, to that number from the Republican National Committee. Msg&data rates may apply. Reply HELP for help, STOP to end. Terms & conditions/privacy policy apply 80810-info.com.

Paid for by the Republican National Committee.
Not Authorized By Any Candidate Or Candidate's Committee. www.gop.com